Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-γ production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during viral infections, chronic type I and II IFN signaling can lead to immune suppression and a failure to clear viral infection.51-53”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Self-citationInterferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., & von Herrath, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061462 · Cited by 548
Jacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481
Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling
Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W., & Levy, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.011 · Cited by 470
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Research works printed but not linked: 2
- Brockman MA Blood 2009 114 346 19365081 PMC2714209 · DOI · Paper page
- 10.1089/jir.2012.0037 · DOI
Cited by
Items 601–700 of 713
Agonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro-environmentPreprint
Maltez, V. I., Arora, C., Sor, R., Lian, Q., Vonderheide, R. H., Germain, R. N., & Byrne, K. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.17.512537 · Cited by 3
Liang, Q., Wang, L., Xu, J., Lin, A., Wu, Y., Tao, Q., Zhang, B., Min, H., Song, S., & Gao, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01518-7 · Cited by 2
Malachowski, A. N., Jenberie, S., Dalmo, R. A., & Swain, J. K. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110518 · Cited by 2
Zabiegala, A., Kim, Y., & Chang, K. (2025) · Virology · doi:10.1016/j.virol.2025.110734 · Cited by 3
Type I interferon production in myeloid cells is regulated by factors independent of Ptpn22
Barnes, J., Shaikh, A. F., Bevis, A. M., Cockerham, T., & Orozco, R. C. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlaf063 · Cited by 2
Díaz-Beneitez, E., Concostrina-Martínez, L., Cubas-Gaona, L. L., Martín-Martínez, A., Rodriguez, J. R., Rodríguez, J. F., Almazán, F., & Rodríguez, D. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1767950 · Cited by 2
“…human immunode fi ciency virus (HIV), lymphocytic choriomeningitis virus (LCMV), and severe acute respiratory syndrome coronavirus (SARS-CoV), in which systemic IFN responses contribute to either immune suppression or enhanced pathology (Wilson et al., 2013; Anjum et al., 2021; Teer et al., 2025).”
Laulhé, X., Adda-Bouchard, Y., Lopez, G., Chamberlain, G., Dubreuil, A., Charpentier, T., & Lamarre, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117145 · Cited by 2
Arsenio, J., Kahia, N., Robertson, S., Rodriguez, M., Layug, P. J., Vats, H., Kannan, K., Spicer, V., Ozturk-Aptekmann, A., & Wilkins, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783098 · Cited by 2
“While a role for type I IFNs in T cell exhaustion has been described previously (12, 81, 93, 94, 97), further studies are needed to better understand the impact of early IFN signaling on CD8 + T exhaustion development in a sex-speci fi c manner, and how early type I and type II IFN responses may be…”
Who Defends the Stem Cell’s Citadel?
Strick‐Marchand, H., & Durantel, D. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.02.007 · Cited by 2
Bhattacharyya, M., & Penaloza‐MacMaster, P. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0251 · Cited by 2
“Prior reports have demonstrated that immune exhaustion during chronic infections and cancers can be partially reverted with checkpoint blockade, costimulation triggering,(16) T regulatory cell depletion,(17,18) cytokine modulation, or interferon blockade.(23,24) However, it is unknown whether hematopoietic transplanta…”
BackgroundNennig, K., Murthy, S., Maloney, S., Shaw, T. M., Sharobim, M., Matkovic, E., Fadiran, S., Larsen, M., Ramuta, M. D., Kim, A. S., et al. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012436 · Cited by 2
Sepahpour, T., Alshaweesh, J., Azodi, N., Singh, K., Ireland, D. D. C., Valanezhad, F., Nakamura, R., Satoskar, A. R., Dey, R., Hamano, S., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-01032-6 · Cited by 2
Jo, Y., Greene, T. T., Chiale, C., Zhang, K., Fang, Z., Dallari, S., Marooki, N., Wang, W., & Zúñiga, E. I. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410092122 · Cited by 2
Les cellules dendritiques plasmacytoïdes : nouvel Eldorado de la thérapie antivirale ?
Smith, N., & Herbeuval, J. (2015) · Biologie Aujourd hui · doi:10.1051/jbio/2015017 · Cited by 2
Lee, J., Kim, W. K., Kwon, E.-K., Kim, Y., Shin, H. M., Kim, D. H., Min, C.-K., Choi, J., Lee, W., Choi, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179094 · Cited by 2
Liu, Y.-Z., Han, D., Shi, D., Hong, B., Qian, Y., Wu, Z., Yao, S.-H., Tang, T.-M., Wang, M., Xu, X., et al. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i11.1216 · Cited by 2
Innate Immune Recognition of Hepatitis C Virus
Li, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56098-2_13 · Cited by 3
Aging, Immunosenescence, and Transplantation Tolerance
Rickert, C. G., & Markmann, J. F. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_138 · Cited by 2
Editorial: NK cell reaping of Tfh cells: reckless slaughter or sensible pruning?
Brown, M. G., & Erickson, L. D. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ce0415-175r · Cited by 2
“Thus, future studies will need to address how type I IFN signaling controls NK cell lysis and whether additional mechanisms may operate, as the extent of type I IFN signaling is a major determinant of LCMV persistence [7, 8].”
BackgroundRanti, D. L., Wang, A. Y., Daza, J., Bieber, C., Salomé, B., Merritt, E., Cavallo, J. A., Hegewisch-Solloa, E., Mace, E. M., Farkas, A. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.06.483198 · Cited by 4
“In settings of chronic infection, a host-target stalemate can occur due to persistently elevated interferon signaling, the blockage of which can reduce viral burden (11-13).”
BackgroundErratum: The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
Moffett, H. F., Cartwright, A. N. R., Kim, H., Godec, J., Pyrdol, J. W., Äijö, T., Martínez, G., Rao, A., Lü, J., Golub, T. R., et al. (2017) · Nature Immunology · doi:10.1038/ni1017-1173d · Cited by 2
NEIL1 block IFN-β production and enhance vRNP function to facilitate influenza A virus proliferation
Zhang, H., Li, C., Sun, R., Zhang, X., Li, Z., Hua, D., Yin, B., Yang, L., Zhang, L., & Huang, J. (2024) · npj Viruses · doi:10.1038/s44298-024-00065-x · Cited by 1
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice
Freytag, D., Giorgiutti, S., Hopsomer, G., Wadier, N., Depauw, S., Mertz, P., Augé, F., Carapito, R., Couillin, I., Korganow, A., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00292-6 · Cited by 1
“Among environmental factors potentially implicated in the T cell exhaustion of STING GOF mice, type I IFNs were shown to be dispensable, despite the potential role of these cytokines suggested in the literature (Sumida et al, 2022; Terawaki et al, 2011; Wilson et al, 2013).”
Chronic infection perturbs the affinity hierarchy of antiviral B cells
Dimitrova, M., Abreu-Mota, T., Fixemer, J., Bonilla, W. V., Marx, A., Lu, M., Tintignac, K., Kastner, A. L., Ertuna, Y. I., Florova, M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2532422123 · Cited by 1
“I signaling in chronic LCMV infection (63).”
Hashimoto, M., Nasti, T. H., Jin, H.-T., Bu, M. T., Araki, K., Lee, J., Valanparambil, R. M., Akhtar, A., Khan, M. A., Peng, Z., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427192123 · Cited by 1
“For instance, anti - IFNAR - 1 (MAR1 - 5A3, mIgG1), despite its intact Fc region and frequent use for blocking type I IFN activity in vivo (62, 63), shows limited depletion activity, likely due to the ubiquitous distribution of IFNAR - 1 - expressing cells (64).”
Perineural invasion: A neuroimmune axis mediating immunotherapy resistance across malignancies
Guo, J., Hu, Z., Wu, L., Liu, L., Li, Z., Xiong, L., & Yu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116636 · Cited by 2
The Trouble with “Clean” Mice: How Infection History Alters Host Immune Responses
Chlebicz, M., & Reese, T. A. (2026) · Annual Review of Virology · doi:10.1146/annurev-virology-092623-094931 · Cited by 1
Qian, J., Qian, W., Tang, X., & Yin, Y. (2026) · Frontiers in Bacteriology · doi:10.3389/fbrio.2026.1757036 · Cited by 1
STAT3 operates as an inflammation-dependent transcriptional switch in antiviral NK cells
Grassmann, S. A., Kim, H., Rückert, T., Friedrich, C., Pujol, M., Fan, S. X., Owyong, M., Zhang, J. M., Beroshvili, G., Buchholz, V. R., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aed4832 · Cited by 1
Type I Interferons in Immune Defense Against Streptococci
Kovarik, P., Castiglia, V., & Janos, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-09498-4_4 · Cited by 1
Traitement antiviral: Pour ou contre l’interféron de type I ?
Whitehead, P., Drouet, B., Zagury, D., & Bensussan, A. (2013) · médecine/sciences · doi:10.1051/medsci/20132910008 · Cited by 1
Manske, K., Kallin, N., Bingsch, B., Steiger, K., Thimme, R., Knolle, P. A., & Wohlleber, D. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)31860-9 · Cited by 1
Aging, Immunosenescence, and Transplantation Tolerance
Rickert, C. G., & Markmann, J. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_138-1 · Cited by 2
Alves-Peixoto, P., Férez, M., Knudson, C. J., Melo‐Silva, C. R., Stotesbury, C., Wong, E. B., Correia‐Neves, M., & Sigal, L. J. (2019) · Journal of Virology · doi:10.1128/jvi.01832-19 · Cited by 1
“IFN-I is important for the maintenance of chronic LCMV infection and T-cell dysfunction, because treatment with Abs to IFNAR accelerates recovery from chronic CL13 infection (10, 59).”
BackgroundIntegrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
Wang, N. S., & Maine, C. J. (2020) · Future Drug Discovery · doi:10.4155/fdd-2019-0031 · Cited by 1
Stättermayer, A. F., & Ferenci, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12626 · Cited by 1
Letter: does the IFNL 4 gene discovery really provide a causal role for the IL 28B haplotype blocks?
Galmozzi, E., & Lampertico, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12615 · Cited by 1
Hahm, B. (2024) · Viruses · doi:10.3390/v16121939 · Cited by 1
“However, they could also cause inflammation or support T cell exhaustion in certain chronic viral infections [7,8], requiring in-depth interrogation of their mode of action.”
HIV-Associated Immune Exhaustion
Appay, V., Lissina, A., & Sauce, D. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_186-1 · Cited by 1
“Master regulators of these pathways are likely to be type I interferons (Teijaro et al. 2013; Wilson et al. 2013), whose adverse role in chronic HIV infection appears increasingly evident.”
BackgroundPark, S. B. (2015) · eScholarship (California Digital Library)
The Role of Signal 3 Cytokine Timing in CD8 T Cell Activation: A Dissertation
Urban, S. L. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2wk5z
“animals and anti-IFNAR1 antibody blocking studies found reduced expression of inhibitory molecules, including IL-10 and programmed death-ligand 1 (PD-L1), resulting in viral clearance and restoration of exhausted T cells (9, 43-45).”
BackgroundOsokine, I. (2014) · eScholarship (California Digital Library)
Editorial Commentary: Who is “Special” Now?
Balagopal, A., & Thomas, D. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ382
Immune tolerance by interferon-alpha in experimental arthritis
Chalise, J. P. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-122463
“Recent studies suggest that type I IFN can be detrimental for chronic viral infections, as blockage of type I IFN signalling resulted in effective clearance of persistent lymphocytic choriomeningitis virus (LCMV) (Teijaro et al., 2013, Wilson et al., 2013).”
BackgroundNguyen, J. V. (2015) · OpenBU (Boston University)
Regulation of the germinal center response by T follicular helper cells and type I interferons
Dahlgren, M. W. (2016) · Lund University Publications (Lund University)
Innate Cytokine Responses and Their Functions during Viral Infections
Tarrio, M. L., & Biron, C. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14005-6
Welsh, R. M., & Waggoner, S. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14007-x
Infectious Diseases in Transplantation—Report of the 20th Nantes Actualités Transplantation Meeting
Haspot, F., & Halary, F. A. (2015) · Transplantation · doi:10.1097/tp.0000000000000997
“Two recent publications in ‘Science’ showed that a persistent lymphocytic choriomeningitis virus infection can be impacted by neutralizing the IFN-I pathway with a subsequent expression of interferon-stimulated genes.(18,19) Based on these experimental observations, Alberto Sanchez-Fueyo and co-workers (London, UK) ha…”
BackgroundFighting Chronic Neuroinflammation by Boosting Autoimmunity
Schwartz, M., & Baruch, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00013-1
Induction de la voie IFN/STAT1 dans le cancer du sein sous chimiothérapie : étude mécanistique
Gaston, J. (2016) · theses.fr (ABES) · doi:10.70675/f12f01b9z1813z4194z828cz931e4998f8d1
The T Cell Co-stimulatory Molecule GITR in the Control and Treatment of a Persistent Viral Infection
Clouthier, D. (2015) · TSpace (University of Toronto)
Mechanisms Underlying Plasmacytoid Dendritic Cell Regulation During Viral Infection
Smith, N., & Herbeuval, J. (2017) · Future Virology · doi:10.2217/fvl-2017-0052
Immune Plasticity in Chronic Hepatitis C Virus Patients Treated With Direct-Acting Antivirals
Aljabban, J. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Regulation of Anti-viral Immunity by Dendritic Cells and Natural Killer Cells
Mbanwi, A. N. (2015) · TSpace (University of Toronto)
Exploring the Effect of Chronic Inflammation on Response to Immune Checkpoint Inhibitors in Cancer
El-Refai, S. M. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.045
“Chronic interferon alpha and interferon beta (IFN-α/β) signaling has been shown to induce T cell exhaustion during chronic infection (31).”
BackgroundChang, Y.-H. (2016) · TSpace (University of Toronto) · Cited by 1
SRC FAMILY KINASE MEMBERS MEDIATE TYPE I INTERFERON PRODUCTION BY PLASMACYTOID DENDRITIC CELLS
Dallari, S. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/dallari-simone_phd2015-12-16
Wang, K. C. (2018) · TSpace (University of Toronto)
The pathological significance of abnormal RON and PD-L1 expression in colorectal cancerPreprint
Liu, Y.-Z., Han, D., Shi, D., Hong, B., Qian, Y., Wu, Z., Yao, S.-H., Tang, T.-M., Xu, X.-M., Wang, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-37737/v1
“In tumor cells, long-term continuous activation of IFN-γ can 400 mediate adaptive resistance to PD-L1 tumor immunosuppression; high expression of 401 RON may attenuate resistance, restore the efficacy of PD-L1 targeted therapy, and may 402 even have a promoting effect on the expression of PD-L1 by inhibiting the produ…”
BackgroundDysregulation of immune gene expression profiles during HTLV-1 infection
Keikha, M., Ali‐Hassanzadeh, M., Bagheri, R., & Karbalaei, M. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100944
Young, H. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736703662.793565772
HIV-Associated Immune Exhaustion
Appay, V., Lissina, A., & Sauce, D. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_186
Clairambault, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736362848.793575385
Nice, T. J., Osborne, L. C., Tomov, V. T., Artis, D., Wherry, E. J., & Virgin, H. W. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006223
Feldmann, H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733826164.793551587
Inoue, K., Schanne, D. H., Matsui, A., Lei, P., Klein, S., Aoki, S., Taniguchi, H., Kikuchi, H., Jiang, C., Liu, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.29.497540
“In addition, anti-IFNAR1 antibody alleviates T cell exhaustion and 330 immunosuppression through IFN-γ production (46, 47).”
BackgroundRole of HDAC5 and SIRT2 in depression and clinical efficacy of antidepressants
Cortés-Erice, M. (2022) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/64991
Svanberg, C. (2023) · Linköping University medical dissertations · doi:10.3384/9789180751230
Improving Cancer Epigenetic Therapy; A Glimpse of NRF2
Kashkoulinejad-Kouhi, T. (2023) · Journal of Cellular Signaling · doi:10.33696/signaling.4.095
“The question raised is whether the chronic exposure to exogenous viral infection leads to an immune exhaustion and reduces immune response [65].”
BackgroundStudstill, C. J. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/88918
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
Zander, R., & Cui, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00278-7
Erfassung und Bewertung der Immunzell-Dynamik ausgehend vom Transkriptom der Milz
Seth, C. M. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-37129
Primed to overreact: virus-induced IFN contributes to antibody-mediated anaphylaxis
Penaloza-MacMaster, P. A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci203729
Spatial interferon circuits establish checkpoint control of progenitor exhausted CD8 T cells
Liu, S., Elsaesser, H. J., Quevedo, R. V., Xu, W., Abd-Rabbo, D., Bertol, B. C., Liu, M. Y. R., Lukhele, S., Lamorte, S., McGaha, T. L., et al. (2026) · Cell Press Blue · doi:10.64898/2026.03.01.708869
Self-citationCytolysis limits IFN-I and effector memory CD8 T cells after viral vector vaccination
Penaloza-MacMaster, P. A. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102885
Rôle de l'IFN-a4 dans l'établissement de la chronicité virale
Taleb, K. (2014) · theses.fr (ABES) · doi:10.70675/cae5f2fbzf132z4dd2za72bz03b4b3697ed3
Characterization of Arenaviridae nucleases and design of inhibitors
Yekwa, E. L. (2017) · theses.fr (ABES) · doi:10.70675/fd141c5fz0b58z443ez9904zfe9e99196053
Griesbeck, M. (2015) · theses.fr (ABES) · doi:10.70675/fbf468f5z3908z43ecz93f3z444bd68d791b
“… a critical role of the toll-‐like receptor 7 (TLR7) pathway and resulting type I interferon (IFN) production in the outcome of these diseases (Bao & Liu, 2013; Di Domizio et al, 2009; Ganguly et al, 2009; Teijaro et al, 2013; Wilson et al, 2013).”
InfluentialMadelain, V. (2018) · theses.fr (ABES) · doi:10.70675/0b523310ze626z4941z8b3dzcec30873ff53 · Cited by 1
Néogenèse lymphoïde au cours du lupus : mécanismes fondamentaux et pistes thérapeutiques
Veber, R. (2018) · theses.fr (ABES) · doi:10.70675/cdc0e39czbb69z48eaz8281z13f8ffb581dd
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Labarthe, L. (2020) · theses.fr (ABES) · doi:10.70675/8e0a6f66ze74dz497cz89b5z17639f9eff02 · Cited by 2
Rôle de TRIM33 dans l'immunothérapie anti-tumorale radio-induite
Assouvie, A. (2021) · theses.fr (ABES) · doi:10.70675/bc108f50z5815z424dz84c9z480836dbb865
Nebot-Bral, L. (2021) · theses.fr (ABES) · doi:10.70675/e1797b79z28d4z4e65zbd29zdc771b604d21
Immunosénescence, inflammation et immunothérapies
Naigeon, M. (2022) · theses.fr (ABES) · doi:10.70675/f0b0b5e9zc57dz4931z82c0z1510abbc8c2c
Single cell monitoring of antiviral response regulation upon viral infection
Ribeiro, M. M. S. (2022) · theses.fr (ABES) · doi:10.70675/ad14ca1bzc138z439ezaea2z978adb91e70c
Pouxvielh, K. (2024) · theses.fr (ABES) · doi:10.70675/78db399bzce6az4d34z9634zfbe1e4580685
Metadata
- Authors
- Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G.
- Affiliations
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Brooks, David G.
- ORCID
- Venue
- Science
- Published
- 2013-04-12
- Volume
- 340
- Issue
- 6129
- Pages
- 202-207
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3704950
- OpenAlex
- W2049868800
- Cited by
- 709
- References
- 29
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 34 · 2023: 35 · 2022: 35 · 2021: 48 · 2020: 50 · 2019: 50 · 2018: 58 · 2017: 72 · 2016: 87 · 2015: 72 · 2014: 70 · 2013: 34
- FWCI
- 48.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000077)
- National Heart, Lung, and Blood Institute (R01HL108949, HL108949)
- National Institute of Allergy and Infectious Diseases (AI060567, T32AI060567, U01AI082975, R01AI085043, AI082975, R01AI056154, AI085043, R01AI047868, P30AI028697)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR063020)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- type I interferon signaling, chronic infection, lymphocytic choriomeningitis virus, viral persistence, immune activation, immunosuppression, CD4+ T cells, interferon-gamma, antiviral immunity, viral clearance
- MeSH terms
- Animals, Antibodies, Arenaviridae Infections, Dendritic Cells, Immune Tolerance, Interferon Type I, Interferon-gamma, Lymphocytic choriomeningitis virus, Virus Replication, Signal Transduction, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-10, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice, Receptor, Interferon alpha-beta, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.